Abstract
BackgroundTo investigate the three-dimensional (3D) distribution patterns of clinically metastatic (positive) lymph nodes on pretreatment computed tomography (CT)/magnetic resonance imaging (MRI) images of patients with locally advanced cervical cancer.MethodsWe enrolled 114 patients with uterine cervical cancer with positive nodes by CT/MRI (≥10 mm in the shortest diameter). Pretreatment CT/MRI data were collected at 6 institutions. The FIGO stage was IB1 in 2 patients (2%), IB2 in 6 (5%), IIA in 3 (3%), IIB in 49 (43%), IIIB in 50 (44%), and IVA in 4 (4%) patients. The median cervical tumor diameter assessed by T2-weighted MRI was 55 mm (range, 10–87 mm). The anatomical distribution of the positive nodes was evaluated on CT/MRI images by two radiation oncologists and one diagnostic radiologist.ResultsIn these patients, 273 enlarged nodes were assessed as positive. The incidence of positive nodes was 104/114 (91%) for the obturator region, 31/114 (27%) for the external iliac region, 16/114 (14%) for the internal iliac region, 22/114 (19%) for the common iliac region, and 6/114 (5%) for the presacral region. The external iliac region was subdivided into four sub-regions: lateral, intermediate, medial, and caudal. The obturator region was subdivided into two sub-regions: cranial and caudal. The majority of patients had positive nodes in the cranial obturator and/or the medial external iliac region (111/114). In contrast, few had positive nodes in the lateral external iliac, caudal external iliac, caudal obturator, internal iliac and presacral regions. All cases with positive nodes in those low-risk regions also had positive nodes in other pelvic nodal regions concomitantly. The incidence of positive nodes in the low-risk regions/sub-regions was significantly related to FIGO stage (p=0.017) and number of positive nodes (p<0.001).ConclusionsWe demonstrated the 3D distribution patterns of clinical metastatic pelvic lymph nodes on pretreatment CT/MRI images of patients with locally advanced cervical cancer. These findings might contribute to future individualization of the clinical target volume of the pelvic nodes in patients with cervical cancer.
Highlights
To investigate the three-dimensional (3D) distribution patterns of clinically metastatic lymph nodes on pretreatment computed tomography (CT)/magnetic resonance imaging (MRI) images of patients with locally advanced cervical cancer
Treatment planning for uterine cervical cancer has transitioned from a two-dimensional (2D) approach based on bony landmarks to a three-dimensional (3D) technique based on computed tomography (CT)/magnetic resonance imaging (MRI)
Guidelines that provide a standard definition of clinical target volume (CTV) nodes are published by the Radiation Therapy Oncology Group (RTOG) [2], United Kingdom (UK) investigators [3] and the Japan Clinical Oncology Group (JCOG) [4]
Summary
To investigate the three-dimensional (3D) distribution patterns of clinically metastatic (positive) lymph nodes on pretreatment computed tomography (CT)/magnetic resonance imaging (MRI) images of patients with locally advanced cervical cancer. Guidelines that provide a standard definition of CTV nodes are published by the Radiation Therapy Oncology Group (RTOG) [2], UK investigators [3] and the Japan Clinical Oncology Group (JCOG) [4]. These guidelines were developed mainly from information on the normal anatomical pelvic lymph node distribution. If areas with a low risk of node metastases could be deleted from the CTV, toxicity could be reduced without sacrificing regional control
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have